Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 21 articles: HTML format

Single Articles

February 2024
1. LOU H, Cai H, Huang X, Li G, et al
   Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
   Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
   PubMed     Abstract available
   
   
   January 2024
2. LUKOVIC J, Pintilie M, Han K, Fyles AW, et al
   An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer.
   Clin Cancer Res. 2024 Jan 5. doi: 10.1158/1078-0432.CCR-23-2085.
   PubMed     Abstract available
   
   
   
3. OAKNIN A, Ghamande SA, Kasamatsu Y, Gil-Martin M, et al
   Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer.
   Clin Cancer Res. 2024 Jan 2. doi: 10.1158/1078-0432.CCR-23-1829.
   PubMed     Abstract available
   
   
   August 2023
4. FRIEDMAN CF, Ravichandran V, Miller K, Vanderbilt C, et al
   Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
   Clin Cancer Res. 2023 Aug 29:CCR-23-1078. doi: 10.1158/1078-0432.CCR-23-1078.
   PubMed     Abstract available
   
   
   December 2022
5. LYNG H, Skipar K, Hompland T
   Targeted Therapy on the Screen: Do We Hit the Target?
   Clin Cancer Res. 2022;28:5233-5234.
   PubMed     Abstract available
   
   
   November 2022
6. HILLEMANNS P, Denecke A, Woelber L, Bohmer G, et al
   A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial.
   Clin Cancer Res. 2022;28:4885-4892.
   PubMed     Abstract available
   
   
   October 2022
7. GHOSH S, Mazumdar T, Xu W, Powell RT, et al
   Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
   Clin Cancer Res. 2022;28:4479-4493.
   PubMed     Abstract available
   
   
   September 2022
8. AN J, Tang J, Li BX, Xiong H, et al
   Efficacy and Safety of the Anti-PD-L1 Monoclonal Antibody Socazolimab for Recurrent or Metastatic Cervical Cancer: A Phase I Dose-Escalation and Expansion Study.
   Clin Cancer Res. 2022 Sep 22. pii: 709354. doi: 10.1158/1078-0432.CCR-22-1280.
   PubMed     Abstract available
   
   
   August 2022
9. HAN K, Fyles A, Shek T, Croke J, et al
   A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
   Clin Cancer Res. 2022 Aug 29. pii: 708819. doi: 10.1158/1078-0432.CCR-22-1665.
   PubMed     Abstract available
   
   
   
10. MILLER KM, Friedman CF
    Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical Cancer.
    Clin Cancer Res. 2022 Aug 10. pii: 707611. doi: 10.1158/1078-0432.CCR-22-1779.
    PubMed     Abstract available
    
    
    June 2022
11. FENG J, Tang D, Wang J, Zhou Q, et al
    SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, for recurrent or metastatic cervical cancer: a clinical expansion cohort of phase 1 study.
    Clin Cancer Res. 2022 Jun 2. pii: 699316. doi: 10.1158/1078-0432.CCR-22-0346.
    PubMed     Abstract available
    
    
    March 2022
12. VAN DEN HELDER R, Steenbergen RDM, van Splunter AP, Mom CH, et al
    HPV AND DNA METHYLATION TESTING IN URINE FOR CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL CANCER DETECTION.
    Clin Cancer Res. 2022 Mar 10. pii: 682143. doi: 10.1158/1078-0432.CCR-21-3710.
    PubMed     Abstract available
    
    
    September 2021
13. ROCKALL AG, Barwick TD, Wilson W, Singh N, et al
    DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA.
    Clin Cancer Res. 2021 Sep 15. pii: 1078-0432.CCR-21-1834.
    PubMed     Abstract available
    
    
    August 2021
14. WILLIAMSON CW, Zamarin D, Mayadev J
    Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
    Clin Cancer Res. 2021;27:4136-4138.
    PubMed     Abstract available
    
    
    July 2021
15. MONDINI M, Deutsch E
    (Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?
    Clin Cancer Res. 2021;27:3815-3817.
    PubMed     Abstract available
    
    
    
16. JEANNOT E, Latouche A, Bonneau C, Calmejane MA, et al
    Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer.
    Clin Cancer Res. 2021 Jul 1. pii: 1078-0432.CCR-21-0625.
    PubMed     Abstract available
    
    
    April 2021
17. FERRALL L, Lin KY, Roden RBS, Hung CF, et al
    Cervical Cancer Immunotherapy: Facts and Hopes.
    Clin Cancer Res. 2021 Apr 22. pii: 1078-0432.CCR-20-2833.
    PubMed     Abstract available
    
    
    
18. FLOBERG JM, Zhang J, Muhammad N, DeWees TA, et al
    Standardized Uptake Value for 18F-Fluorodeoxyglucose is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer.
    Clin Cancer Res. 2021 Apr 5. pii: 1078-0432.CCR-20-4450.
    PubMed     Abstract available
    
    
    March 2021
19. CHEN J, Chen C, Zhan Y, Zhou L, et al
    Heterogeneity of interferon-mediated responses and tumor immunogenicity in cervical cancer patients receiving concurrent chemoradiotherapy.
    Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-20-4521.
    PubMed     Abstract available
    
    
    April 2020
20. CHOI YJ, Hur SY, Kim TJ, Hong SR, et al
    A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3.
    Clin Cancer Res. 2020;26:1616-1623.
    PubMed     Abstract available
    
    
    December 2019
21. LI F, Zhang Z, Cai J, Chen X, et al
    Primary preclinical and clinical Evaluation of 68Ga-DOTA-TMVP1 as a novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer.
    Clin Cancer Res. 2019 Dec 16. pii: 1078-0432.CCR-19-1845.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.